Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: A case of immune reconstitution inflammatory syndrome

Pediatric Infectious Disease Journal

Volumn 23, Issue 7, 2004, Pages 683-685

  Nuttall, James J C ^a   Wilmshurst, Jo M ^a   Ndondo, Alvin P ^a   Yeats, Jane ^a   Corcoran, Craig ^a   Hussey, Gregory D ^a   Eley, Brian S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Highly active antiretroviral therapy; Immune restoration disease; Pediatric human immunodeficiency virus; Progressive multifocal leukoencephalopathy

Indexed keywords

EFAVIRENZ; GLUCOCORTICOID; LAMIVUDINE; PREDNISONE; STAVUDINE;

ARTICLE; BRAIN DYSFUNCTION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DIZZINESS; HEADACHE; HEMIPARESIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; MALE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SCHOOL CHILD; VIRUS IDENTIFICATION; VOMITING;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; GLUCOCORTICOIDS; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; PREDNISONE; SYNDROME;

EID: 3142724686     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000130954.41818.07     Document Type: Article

References (12)

1. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973;127:467-470.
2. Mamidi A, DeSimone JA, Pomerantz R. Central nervous system infections in individuals with HIV infection. J Neurovirol. 2002;8:158-162.
3. Morriss MC, Rutstein RM, Rudy B, Desrochers C, Hunter JV, Zimmerman RA. Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuroradiology. 1997;39:142-144.
4. Inui K, Miyagawa H, Sashihara J, et al. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain Dev. 1999;21:416-419.
5. Berger JR, Scott G, Albrecht J, Belman AL, Tomatore C, Major E. Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS. 1992;6:837-841.
6. Du Pasquier RA, Koralnik IJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol. 2003;9:25-31.
7. Miralles P, Berenguer J, Lacruz C, et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS. 2001;15:1900-1902.
8. Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS. Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? Am J Med. 1998;105:541-543.
9. Collazos J, Mayo J, Martinez E, Blanco MS. Contrast enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS. 1999;13:1426-1428.
10. Giudici B, Vaz B, Bossolasco S. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis. 2000;30:95-99.
11. McComsey GA, Whalen CC, Mawhorter SD, et al. Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS. 2001;15:321-327.
12. Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis. 2002;35:1250-1257.